# Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

> **NCT05619653** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Valentina Puentmann** · enrollment: 279 (actual)

## Conditions studied

- COVID-19 Associated Cardiac Involvement
- Remodeling, Left Ventricle
- Remodeling, Vascular
- Left Ventricular Dysfunction
- Exercise Intolerance
- Vascular Inflammation
- Microvascular Angina
- Long COVID
- Myocarditis, Pericarditis

## Interventions

- **DRUG:** Prednisolone
- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT05619653
- **Lead sponsor:** Valentina Puentmann
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-12-12
- **Primary completion:** 2025-08-08
- **Final completion:** 2026-03-31
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05619653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05619653, "Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05619653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*